Details
Stereochemistry | ACHIRAL |
Molecular Formula | C14H18ClN2O2 |
Molecular Weight | 281.758 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 1 |
SHOW SMILES / InChI
SMILES
C[N+](C)(C)CC#CCOC(=O)NC1=CC=CC(Cl)=C1
InChI
InChIKey=DDKOMKXCUXCQBS-UHFFFAOYSA-O
InChI=1S/C14H17ClN2O2/c1-17(2,3)9-4-5-10-19-14(18)16-13-8-6-7-12(15)11-13/h6-8,11H,9-10H2,1-3H3/p+1
4-(M-Chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium (McN-A-343) is a selective muscarinic M1 receptors agonist, which leads to its widespread use as an aid to distinguish responses mediated through M₁ receptors from those utilizing M₂ or M₃ muscarinic receptor subtypes, especially in the CNS. McN-A-343 has a number of non-muscarinic actions. These include activation of some types of nicotinic acetylcholine receptors, antagonism of serotonin 5-HT₃ and 5-HT₄ receptor subtypes, inhibition of the uptake mechanism and a local anesthetic action.
Originator
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: P11229 Gene ID: 1128.0 Gene Symbol: CHRM1 Target Organism: Homo sapiens (Human) Sources: https://www.ncbi.nlm.nih.gov/pubmed/22643681 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
PubMed
Title | Date | PubMed |
---|---|---|
Functional determination of McN-A-343 affinity for M1 muscarinic receptors. | 1990 Apr |
|
A novel mechanism of G protein-coupled receptor functional selectivity. Muscarinic partial agonist McN-A-343 as a bitopic orthosteric/allosteric ligand. | 2008 Oct 24 |
|
Investigating the interaction of McN-A-343 with the M2 muscarinic receptor using its nitrogen mustard derivative. | 2010 Apr 1 |
|
The pharmacology of McN-A-343. | 2012 Aug |
Patents
Sample Use Guides
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/29290419
The selective M1-receptor agonist McN-A-343 ((4-(M-Chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium ) (100μM) induced a current similar to the CCh-activated current in sinus rhythm atrial cardiomyocytes pretreated with pertussis toxin to inhibit M2-receptor-mediated Gi-protein signaling, which was abolished by MT-7.
Name | Type | Language | ||
---|---|---|---|---|
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
JO67EL43YO
Created by
admin on Sat Dec 16 04:41:31 GMT 2023 , Edited by admin on Sat Dec 16 04:41:31 GMT 2023
|
PRIMARY | |||
|
DTXSID70226997
Created by
admin on Sat Dec 16 04:41:31 GMT 2023 , Edited by admin on Sat Dec 16 04:41:31 GMT 2023
|
PRIMARY | |||
|
7614-29-1
Created by
admin on Sat Dec 16 04:41:31 GMT 2023 , Edited by admin on Sat Dec 16 04:41:31 GMT 2023
|
PRIMARY | |||
|
4022
Created by
admin on Sat Dec 16 04:41:31 GMT 2023 , Edited by admin on Sat Dec 16 04:41:31 GMT 2023
|
PRIMARY |
SUBSTANCE RECORD